David J. Pinato

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

David J. Pinato, Sarah Howlett, Diego Ottaviani et al. · JAMA Oncology · 2019 · 564 citations · Full text

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

David J. Pinato, Bernard V. North, Rohini Sharma · British Journal of Cancer · 2012 · 413 citations · Full text

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

David J. Pinato, Rohini Sharma, Elias Allara et al. · Journal of Hepatology · 2016 · 413 citations · Full text

Hepatology, Albi Grade, Medicine +12

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 284 citations · Full text